Spots Global Cancer Trial Database for metastatic esophageal cancer
Every month we try and update this database with for metastatic esophageal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer | NCT02843581 | Metastatic Esop... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Peri-operative Zimberelimab (Anti-PD-1) vs Zimberelimab in Combination With Domvanalimab (Anti-TIGIT) in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC) | NCT06250036 | Metastatic Esop... Metastatic Gast... | Single agent zi... Combination zim... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | NCT00453323 | Esophageal Canc... | Paclitaxel Capecitabine | 18 Years - | National Cancer Center, Korea | |
| Apatinib for Metastatic Esophageal Cancer. | NCT02544737 | Esophageal Canc... Metastatic Esop... Apatinib | Apatinib | 19 Years - | Hangzhou Cancer Hospital | |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | NCT00130689 | Esophageal Canc... Gastric Cancer Neoplasm Metast... | Cetuximab | 18 Years - | Dana-Farber Cancer Institute | |
| WaKING: Wnt and checKpoint INhibition in Gastric Cancer | NCT04166721 | Metastatic Esop... Metastatic Gast... | Atezolizumab | 18 Years - | Royal Marsden NHS Foundation Trust | |
| A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer | NCT06251973 | Metastatic Esop... Advanced Unrese... Metastatic Gast... Metastatic Gast... Metastatic Esop... Metastatic Esop... Metastatic Gast... Metastatic Gast... Unresectable Es... Unresectable Es... Unresectable Ga... Unresectable Ga... Unresectable Ga... | AgenT-797 Botensilimab Balstilimab Ramucirumab Paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer | NCT00130689 | Esophageal Canc... Gastric Cancer Neoplasm Metast... | Cetuximab | 18 Years - | Dana-Farber Cancer Institute | |
| SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer | NCT02545751 | Esophageal Canc... Metastatic Esop... Stereotactic Bo... Thymalfasin | Stereotactic Bo... Thymalfasin | 19 Years - | Hangzhou Cancer Hospital | |
| Peri-operative Zimberelimab (Anti-PD-1) vs Zimberelimab in Combination With Domvanalimab (Anti-TIGIT) in Resectable Mismatch Repair Deficient/Micro-satellite Unstable Gastric and Gastro-oesophageal Junctional Adenocarcinoma (ZODIAC) | NCT06250036 | Metastatic Esop... Metastatic Gast... | Single agent zi... Combination zim... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Combination of Cryosurgery and NK Immunotherapy for Advanced Esophageal Cancer | NCT02843581 | Metastatic Esop... | Cryosurgery NK immunotherap... | 30 Years - 70 Years | Fuda Cancer Hospital, Guangzhou | |
| Paclitaxel and Capecitabine in Patients With Metastatic/Recurrence Esophageal Cancer | NCT00453323 | Esophageal Canc... | Paclitaxel Capecitabine | 18 Years - | National Cancer Center, Korea |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
